← Back to headlines
Guggenheim Raises Price Target for AstraZeneca PLC
Guggenheim has increased its price target for pharmaceutical giant AstraZeneca PLC (AZN) from 15,500 GBp to 16,000 GBp, indicating a more optimistic outlook for the company's stock.
16 Mar, 18:21 — 16 Mar, 18:21
Sources
Showing 1 of 1 sources
Related Stories
Nvidia Reports Record Second-Quarter Earnings Driven by Surging AI Demand
57m ago
Universal Studios Japan Announces Nearly $2 Billion Expansion Project
1h ago
Nvidia Earnings Fuel Broad Market Rally Ahead of Jackson Hole Symposium
1h ago
Mixed Corporate Earnings Drive Market Movements as Burlington Slides
1h ago